Characterisation of plasmablast-derived HBsAg-specific antibody and its structural basis for binding to native HBsAg dimer
Authors:
Open Access
Abstract
Background: Plasmablast-derived HBV surface antigen (HBsAg)-specific monoclonal antibody (mAb) and structural basis for binding to native HBsAg are poorly known. Objective: We aimed to identify plasmablast-derived HBsAg-specific mAbs, evaluate their antiviral activities and resolve their structure for binding to native HBsAg. Design: A previously vaccinated volunteer was enrolled in this study, who was boosted with a dose of recombinant hepatitis B vaccine and donated the blood sample. Activated plasmablasts were sorted from fresh peripheral blood mononuclear cells and mAbs were expressed. Their gene features, cross-genotypic binding activities and antiviral functions in vitro and in vivo were comprehensively analysed. The cryo-electron microscopy (cryo-EM) was used to determine the structure of representative mAb bound to the native HBsAg. Results: In this study, we cloned a series of HBsAg-specific mAbs directly from clonally expanded plasmablasts from a vaccinated individual. Most of the mAbs displayed cross-reactivities of binding to different genotype HBsAg proteins and antiviral functions such as neutralisation and antibody-dependent cellular phagocytosis. These human anti-HBsAg mAbs, especially SY-4-class and SY-23-class, could be good candidates for antibody drugs. The cryo-EM structure of SY-23 bound to the dimeric HBsAg was determined, revealing its binding mechanism and unprecedented structural detail of the major antigenic loop (AGL) of HBsAg. Conclusion: Overall, our work has uncovered the diverse gene features and varied anti-HBV activities of plasmablast-derived mAbs, providing a series of antibody drug candidates and the long-sought-after atomic model of AGL has paved the way for a wholistic characterisation of the AGL’s dynamic conformation during HBV infection and immune response.Keywords
Funding Information
- the Science and Technology Talent Service Enterprise Project (2024DJC064)
- the Shenzhen Science and Technology Program (JCYJ20200109144201725)
- the Shenzhen Science and Technology Program (JCYJ20220530163412028)
- the Shenzhen Science and Technology Program (JCYJ20250604143909012)
- the Shenzhen Science and Technology Program (RCYX20200714114700046)
- the Shenzhen Science and Technology Program (ZDSYS20210623091810030)
- the East Lake Hi-tech Development Zone Unveiling and Commanding Project (2023KJB219)
- The National Natural Science Foundation of China (81971936)
- The National Natural Science Foundation of China (82025022)
- The National Natural Science Foundation of China (82171752)
- The National Natural Science Foundation of China (82201951)
- The National Natural Science Foundation of China (82322040)
- The National Science and Technology Major Project of China (2025ZD01904200)
- The National Science and Technology Major Project of China (2025ZD01904201)
- The Guangdong Innovative and Entrepreneurial Research Team Program (2023ZT10Y013)
- The Shenzhen High-level Hospital Construction Fund (23250G1002)
- The Shenzhen High-level Hospital Construction Fund (23250G1003)
- the Guangdong Basic and Applied Basic Research Foundation (2021B1515020034)
This publication has 85 references indexed in Scilit:
- Targeting hepatitis B virus-associated nephropathy: efficacy and challenges of current antiviral treatmentsClinical and Experimental Medicine, 2025
- A novel method for recombinant mammalian‐expressed S‐HBsAg virus‐like particle production for assembly status analysis and improved anti‐HBs serologyProtein Science, 2024
- An image processing pipeline for electron cryo‐tomography in RELION‐5FEBS Open Bio, 2024
- Endoplasmic reticulum stress promotes HBV production by enhancing use of the autophagosome/multivesicular body axisHepatology, 2021
- UCSF ChimeraX: Structure visualization for researchers, educators, and developersProtein Science, 2020
- Updates on Chronic HBV: Current Challenges and Future GoalsCurrent Treatment Options in Gastroenterology, 2019
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidanceHepatology, 2018
- Human monoclonal antibody against Hepatitis B virus surface antigen (HBsAg)Antiviral Research, 2007
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Computer Visualization of Three-Dimensional Image Data Using IMODJournal of Structural Biology, 1996